Utipro® Plus AF Named Best Women’s Product at the OTC Awards 2026

Noventure | Utipro® Plus AF, Official Winner of Best Women's Product at the OTC Awards 2026

Our partner Pamex Limited collected the award in Ireland, recognising Utipro® Plus AF in women’s health.

Utipro® Plus AF has been named Best Women’s Product at the OTC & Retail Pharmacy Product Awards 2026, organised by Irish Pharmacy News. The award was collected by our partner Pamex Limited, which distributes Utipro® Plus AF in Ireland.

Recognised by the Pharmacy Sector

The OTC & Retail Pharmacy Product Awards are judged by pharmacy professionals and highlight the products that stand out in Irish pharmacies each year. It is a recognition we value especially, as it comes from the professionals who advise women at the pharmacy counter every day.

An Antibiotic-Free Approach to Cystitis

Utipro® Plus AF is a medical device for the control and prevention of uncomplicated urinary tract infections (cystitis). Its formulation combines xyloglucan, gelose, propolis and Hibiscus sabdariffa, ingredients of natural origin, with a dual mode of action in the bowel and the bladder. In the intestine, xyloglucan and gelose act mechanically, limiting contact between pathogens such as E. coli and the intestinal mucosa, the first step before they reach the urinary tract. In the bladder, propolis and hibiscus help create an environment less favourable to bacterial growth. Its use is supported by published clinical studies.

Congratulations to the Pamex Team

This award belongs to the Pamex team, whose work with pharmacists and healthcare professionals has brought Utipro® Plus AF to women across Ireland. We are proud to share this milestone with them.

Discover Utipro® Plus AF · Partnering with Noventure

Utipro® Plus AF is a CE-marked medical device (Class III, EU MDR). Read the instructions for use carefully.